Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

@article{Gendelman2015NanoneuromedicinesFD,
  title={Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.},
  author={Howard E. Gendelman and Vellareddy Anantharam and Tatiana K. Bronich and Shivani Ghaisas and Huajun Jin and Anumantha G Kanthasamy and Xinming Liu and JoEllyn McMillan and R. Lee Mosley and Balaji Narasimhan and S K Surya K Mallapragada},
  journal={Nanomedicine : nanotechnology, biology, and medicine},
  year={2015},
  volume={11 3},
  pages={751-67}
}
Interest in nanoneuromedicine has grown rapidly due to the immediate need for improved biomarkers and therapies for psychiatric, developmental, traumatic, inflammatory, infectious and degenerative nervous system disorders. These, in whole or in part, are a significant societal burden due to growth in numbers of affected people and in disease severity. Lost productivity of the patient and his or her caregiver, and the emotional and financial burden cannot be overstated. The need for improved… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
9 Extracted Citations
167 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-9 of 9 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 167 references

The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein—proofs of crossing blood–brain-barrier

  • A Janaszewska, B Ziemba, K Ciepluch, D Appelhans, B Voit, B Klajnert
  • New J Chem 2012;36:350-3
  • 2012
Highly Influential
11 Excerpts

Similar Papers

Loading similar papers…